PFIZER INC (PFE)
About PFIZER INC
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $62.6B
- Net income
- $7.8B
- Total assets
- $208.2B
- Market cap
- $148.4B
- Gross margin
- 74.3%
- Operating margin
- 12.0%
- Net margin
- 12.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $62.6B
- Cost of revenue
- $16.1B
- Gross profit
- $46.5B
- Operating expenses
- $39.0B
- Operating income
- $7.5B
- Income tax
- -$266.0M
- Net income
- $7.8B
- EPS (basic)
- $1.37
- EPS (diluted)
- $1.36
Balance sheet
- Total assets
- $208.2B
- Current assets
- $42.9B
- Total liabilities
- $121.4B
- Current liabilities
- $37.0B
- Shareholders’ equity
- $86.8B
Cash flow
- Operating cash flow
- $11.7B
- Investing cash flow
- -$1.4B
- Financing cash flow
- -$10.3B
- Net cash flow
- $90.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $148.4B
- P/E ratio
- 18.0
- EPS (diluted)
- $1.36
- Dividend yield
- 7.01%
- Shares outstanding
- 6.0B
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 22, 1951
Pfizer Inc (PFE) Stock Price
- Profitable — net income of $7.8B in FY2025.
- Revenue declined 23% from FY2021 to FY2025.
- Gross margin of 74.3%, net margin 12.5%.
- Trading 14% below its 52-week high.
- Pays a dividend yielding about 7.01% annually.
- Valued at a price-to-earnings (P/E) ratio of 18.0.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PFIZER INC.
Write a review
News about PFIZER INC
News & sentiment via Polygon.io
Pfizer Inc: frequently asked questions
Is Pfizer Inc an American company?
Yes — Pfizer Inc is an American company headquartered in New York, New York. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Pfizer Inc headquartered?
Pfizer Inc is headquartered in New York, New York, United States.
Is Pfizer Inc publicly traded?
Yes — Pfizer Inc is a publicly traded company. Its stock trades under the ticker symbol PFE on the NYSE.
What does Pfizer Inc do?
Pfizer Inc is an American Pharmaceuticals company in the Health & Beauty sector.
When was Pfizer Inc founded?
Pfizer Inc was founded in 1849.
